Interlab and the Alliance Global Group sign Distribution Agreement

Dubai, 30 September 2013

Interlab (Italy) signed an exclusive master distribution agreement with the AGBL Group (Dubai, UAE) to bring Interlab's Clinical Electrophoresis to AGBL's markets

"Interlab products are positioned to fit customers' needs for serum, urine, and Bence Jones protein electrophoresis, serving both low to high throughput laboratories. Interlab offers fully automated FDA accredited Clinical Electrophoresis Systems. We believe it is a great addition to AGBL's Diagnostics portfolio", says Hassan Tabbarah, Diagnostics Product Manager at Alliance Global.

Interlab offers 2 platforms:

- Easy Interlab G26: The fully automated, compact bench-top, agarose gel electrophoresis system. The system uses the Gold Standard Agarose Gels with positive sample identification, primary tube sampling, and simplified robotics delivering fast, precise, and complete walk-away electrophoresis to any laboratory.

- Pretty Interlab: The smallest fully automated agarose gel electrophoresis analyzer. Uses simple and fast steps to start the analysis with an output of 26 results in less than 45 minutes.

-Ends-

About Interlab
Interlab was founded in Italy in 1976 and soon became one of the major players in the Clinical Electrophoresis market. Interlab is an FDA accredited company as well as ISO 9001 and ISO 13485 certified. The company's philosophy is to follow the strict rules of the GMP (Good Manufacturing Process) standards. Interlab is highly focused on the automation of clinical electrophoresis field, with over 60% of the company profit invested in R&D.

For more information, please visit: www.interlab-srl.com

About Alliance Global Group (AGBL)
The AGBL Group of companies is the largest biomedical gateway to the emerging markets of the Middle East, Africa and Asia. The group is dedicated to bringing innovative technologies and products to researchers, clinicians, and diagnostic users in the emerging healthcare markets within the MEAA region. The group employs more than 80 specialists and has eight regional offices offering distribution, consulting and product development services to more than 40 quality manufacturers of biomedical technologies. The group's stated mission is to improve the lives of the region's inhabitants through novel biomedical technologies and products.

For more information, please visit: www.agbl.net

ZAWYA NEWSLETTERS

RELATED ARTICLES

ZAWYA NEWSLETTERS

LATEST VIDEO